Notizie AIOM – anno XV
FDA approves new treatment to reduce the risk of breast cancer returning
July 17, 2017 - The U.S. Food and Drug Administration today approved neratinib for the extended adjuvant treatment of early-stage, HER2-positive breast cancer. For patients with this type of cancer, Neratinib is the first extended adjuvant therapy, a form of therapy that ...Leggi tutto
Web-app
Una nuova web-app gratuita, in otto lingue, per computer, tablet e smartphone sul melanoma è disponibile sul sito del Corriere della Sera in collaborazione con l'Associazione Italiana di Oncologia Medica (leggi e scarica). Strumento interattivo in due versioni, per ...Leggi tutto
FDA’s ODAC Unanimously Recommends Biosimilar Versions of Bevacizumab and Trastuzumab
July 14, 2017 - On July 13, the U.S. Food and Drug Administration's (FDA) Oncologic Drugs Advisory Committee (ODAC) unanimously recommended approval of biosimilar versions of bevacizumab and trastuzumab. In the morning session, ODAC members voted 17-0 in favor of approving ...Leggi tutto
New CDC Report Shows Cancer Death Rates Are Higher in Rural America
July 13, 2017 - Despite decreases in cancer death rates nationwide, a new report from the Centers for Disease Control and Prevention (CDC) shows slower reduction in cancer death rates in rural America (a decrease of 1.0% per year) compared with urban America (a decrease ...Leggi tutto
Contemporary Treatment Patterns and Outcomes for Clinical Stage IS Testicular Cancer
Controversy exists regarding the optimal management strategy for clinical stage IS seminomatous (SGCT) and nonseminomatous germ cell tumors (NSGCT) of the testis. To assess contemporary treatment patterns and outcomes for clinical stage IS testicular cancer. Using the National ...Leggi tutto
Clinical utility of circulating DNA analysis for rapid detection of actionable mutations to select metastatic colorectal patients for anti-EGFR treatment
While tumor-tissue remains the ‘gold standard’ for genetic analysis in cancer patients, it is challenged with the advent of circulating cell-free tumor DNA (ctDNA) analysis from blood samples. Here, we broaden our previous study on the clinical validation of ...Leggi tutto
Antiemetic Corticosteroid Rotation from Dexamethasone to Methylprednisolone to Prevent Dexamethasone-Induced Hiccup in Cancer Patients Treated with Chemotherapy: A Randomized, Single-Blind, Crossover Phase III Trial
To assess whether the rotation of dexamethasone to methylprednisolone decreases the intensity of dexamethasone-induced hiccup (DIH) in cancer patients treated with chemotherapy. Adult patients who experienced DIH within 3 days after the administration of dexamethasone as ...Leggi tutto
XXXV CONFERENZA NAZIONALE DI CITOMETRIA Aggiornamenti e Innovazioni della Citometria nelle Applicazioni Cliniche e di Ricerca
Paestum (SA), 3 - 6 ottobre 2017 I Soci AIOM potranno usufruire della stessa quota d'iscrizione ridotta per i Soci GIC Bando per il Premio di Studio “Marcello Spanò” GIC 2017, 31^ edizione, dal titolo: “La Citometria nelle tesi sperimentali ed in ...Leggi tutto